Skip to content
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.
Company
Companies

SUSMED

サスメド

4263 · TSE · Information & Communication · 1 article

Financials Company only

Revenue¥497m+7.4% year on yearCompany only · FY6/26

Ordinary profit−¥326mCompany only · FY6/26

Performance over time

Revenue
¥317mFY6/22
¥531mFY6/23
¥343mFY6/24
¥463mFY6/25
¥497mFY6/26
Ordinary profit
−¥217mFY6/22
−¥44.3mFY6/23
−¥357mFY6/24
−¥295mFY6/25
−¥326mFY6/26
Op. cash flow
−¥165mFY6/22
¥101mFY6/23
−¥231mFY6/24
−¥432mFY6/25
−¥474mFY6/26

People & pay

Employees50 peopleFY6/26

Average salary¥8.84mFY6/26

Average salary is for the parent company's own employees (non-consolidated), as Japanese annual reports disclose it.

Five-year history
Five-year history
Fiscal yearRevenueOrdinary profitEPSTotal assetsNet assetsOp. cash flow
FY6/26¥497m+7.4% year on year−¥325.5m−¥22.71¥4.22bn¥4.07bn−¥474m
FY6/25¥463m+35.1% year on year−¥294.7m−¥17.77¥4.50bn¥4.37bn−¥432m
FY6/24¥343m−35.4% year on year−¥357.2m−¥21.41¥4.93bn¥4.60bn−¥231m
FY6/23¥531m+67.5% year on year−¥44.3m−¥3.09¥5.10bn¥4.87bn¥101m
FY6/22¥317m−¥217.4m−¥15.90¥4.94bn¥4.85bn−¥165m

Per-share figures are as each report states them: a share split is restated only for the year before it, and dividends are as paid.

Figures from annual report S100Z4GF · Japan GAAP. Each figure's years come from one report's five-year summary.

Latest coverage

TSE:4263

  1. SUSMED's insomnia app is on sale, but the year's revenue came from partner milestones

    SUSMED began selling its Medcle insomnia app on 1 June, but the year to June 2026 rested on ¥340mn of partner milestones, ended with a ¥382.7mn net loss, and the annual report gives no sales figures for the app.

5% holders

Latest disclosed holders and exits below 5%.

1 holder · data through

No stored data for this selection.

Exits below 5%

Exits below 5%
HolderStakeChangePurposeFiling
スパークス・アセット・マネジメント株式会社4.00%−1.16 ppAsset manager / trustPure investment based on the discretionary investment contract and investment trust entrustment agreementMachine translated
Original (Japanese)「投資一任契約」及び「投資信託委託契約」 に基づく純投資
Filed  — filing S100Z011

Cross-holdings

Strategic shareholdings and sales, by fiscal year.

3 fiscal years · data through

Balance-sheet value is the reporting company's own listed holdings (its largest holding subsidiary's where marked), carried at market value; the percentage divides it by consolidated net assets in the same annual report.

Cross-holdings
Fiscal year endHoldings (issuers)Balance-sheet value% of consolidated net assetsIssues cutSale proceedsFiling
30 Jun 2024No listed strategic holdings reported————Filed 
30 Jun 2023No listed strategic holdings reported————Filed 
30 Jun 2022No listed strategic holdings reported————Filed